On 11 July 2016, following the audit by the State Institute for Drug Control (SUKL), Slovakia, NPO Petrovax Pharm was once again awarded a certificate confirming the compliance of its production and quality management frameworks with the EU GMP standards. The Company received its first Slovakian EU GMP certificate in 2012. The new one will be valid until 2019.
Petrovax Pharm started exporting pharmaceuticals to Slovakia back in 2002, with Polyoxidonium, an effective and safe multi-purpose therapeutic medicine, piloting the arrangement. Over the years of successful application, the product has become widely recognised by Slovak experts for its high profile of safety and efficacy. The Company intends to expand the range of exported products going forward.
The official acknowledgement of Petrovax Pharm's high production quality by the State Institute for Drug Control of Slovakia will further strengthen the Company's positions in the country and facilitate tapping into the broader market. Currently, NPO Petrovax Pharm is the only Russian producer of immunobiological medicines with both local and international GMP certificates.